The most common genera include Desulfovibrio and Desulfobulbus
Phase 3 clinical trials for retatrutide are continuing through 2026
Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, et al
It is in Phase 3 via Lilly's TRIUMPH programme, with one 2026 secondary estimate placing potential MHRA approval in late 2027 or 2028 [1][2] [unverified]
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomized placebo-controlled trial

Seek Urgent or Emergency Care Do not keep treating sulfur burps at home when they occur with: Severe or persistent abdominal pain, especially pain that radiates to the back Repeated vomiting, inability to keep liquids down, fainting, confusion, or very little urine Vomiting blood or material that looks like coffee grounds Black tarry stool, maroon stool, or visible blood A swollen or increasingly painful abdomen with inability to pass stool or gas Chest pressure, shortness of breath, severe weakness, or pain spreading to the arm, jaw, or back High fever, stiff abdomen, severe diarrhea, or rapidly worsening illness People using semaglutide, tirzepatide, or another GLP-1based medicine should take severe abdominal pain, persistent vomiting, major abdominal swelling, inability to hydrate, or inability to pass stool or gas seriously